Although no significant correlation was found between prognosis and DGKZ expression in breast cancer patients, survival analysis showed that the overall survival (OS) of lung cancer, gastric cancer and renal clear cell cancer patients negatively correlated with DGKZ expression (Supplementary Fig. 1). This evidence concerns the gene DGKZ and clear cell renal carcinoma.